Erste Asset Management’s Bicycle Therapeutics BCYC Stock Holding History

Erste Asset Management’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$58.1K	Hold	14,000	–	–	﹤0.01%	582
2026 Q1	$60.8K	Hold	14,000	–	–	﹤0.01%	589
2025 Q4	$94.9K	Hold	14,000	–	–	﹤0.01%	567
2025 Q3	$107K	Hold	14,000	–	–	﹤0.01%	579
2025 Q2	$101K	Hold	14,000	–	–	﹤0.01%	828
2025 Q1	$126K	Hold	14,000	–	–	﹤0.01%	486
2024 Q4	$204K	Hold	14,000	–	–	﹤0.01%	486
2024 Q3	$325K	Hold	14,000	–	–	﹤0.01%	466
2024 Q2	$284K	Hold	14,000	–	–	﹤0.01%	453
2024 Q1	$344K	Hold	14,000	–	–	﹤0.01%	452
2023 Q4	$262K	Hold	14,000	–	–	﹤0.01%	471
2023 Q3	$283K	Hold	14,000	–	–	﹤0.01%	458
2023 Q2	$349K	Hold	14,000	–	–	0.01%	454
2023 Q1	$305K	Hold	14,000	–	–	0.01%	471
2022 Q4	$414K	Hold	14,000	–	–	0.01%	440
2022 Q3	$333K	Hold	14,000	–	–	0.01%	465
2022 Q2	$240K	Hold	14,000	–	–	0.01%	500
2022 Q1	$596K	Hold	14,000	–	–	0.01%	421
2021 Q4	$822K	Buy	+14,000	New	+$772K	0.01%	378

Other funds holding BCYC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GSK plc London $602M AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Erste Asset Management's BCYC Position: Q2 2026 in Review

Erste Asset Management held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 14,000 shares worth $58.1K. The position accounts for ﹤0.01% of the portfolio, ranked #582.

Erste Asset Management first reported a position in BCYC in Q4 2021 and has held it in 19 quarters since. The position peaked at $822K in Q4 2021. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

Erste Asset Management held 14,000 shares of Bicycle Therapeutics worth $58.1K as of Q2 2026.
Erste Asset Management left its Bicycle Therapeutics share count unchanged in Q2 2026.
Bicycle Therapeutics made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #582 holding.
Erste Asset Management first reported a position in Bicycle Therapeutics in Q4 2021 and has held it in 19 quarters since.
Erste Asset Management's Bicycle Therapeutics position peaked at $822K in Q4 2021.
104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.